European Heart Journal最新文献_第3页

Immune checkpoint inhibitor myocarditis-a score to tell you more. 免疫检查点抑制剂心肌炎-一个分数告诉你更多。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-08-01 DOI: 10.1093/eurheartj/ehaf503

Joerg Herrmann,Alexander R Lyon

引用次数: 0

Adult-onset type 1 diabetes: new insights but still much to learn. 成人发病1型糖尿病：新的见解，但仍有很多需要学习。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-31 DOI: 10.1093/eurheartj/ehaf427

Dianna J Magliano,Olov Rolandsson

引用次数: 0

Standards for cardiac telerehabilitation 心脏远程康复标准

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-31 DOI: 10.1093/eurheartj/ehaf408

Martijn Scherrenberg, Maarten Falter, Ana Abreu, Suleman Aktaa, Stefan Busnatu, Ruben Casado-Arroyo, Paul Dendale, Polychronis Dilaveris, Emanuela T Locati, Elena Marques-Sule, Daniel Neunhaeuserer, Roberto Pedretti, Francesco Perone, Annett Salzwedel, Matthias Wilhelm, Maria Bäck

{"title":"Standards for cardiac telerehabilitation","authors":"Martijn Scherrenberg, Maarten Falter, Ana Abreu, Suleman Aktaa, Stefan Busnatu, Ruben Casado-Arroyo, Paul Dendale, Polychronis Dilaveris, Emanuela T Locati, Elena Marques-Sule, Daniel Neunhaeuserer, Roberto Pedretti, Francesco Perone, Annett Salzwedel, Matthias Wilhelm, Maria Bäck","doi":"10.1093/eurheartj/ehaf408","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf408","url":null,"abstract":"Participation in comprehensive, multidisciplinary cardiac rehabilitation programmes as part of secondary prevention is recommended for patients with cardiovascular disease. However, recent data reveal that participation in cardiac rehabilitation is only around 30%–40% of eligible patients in Europe. Key barriers are practical barriers such as limitations in transport or scheduling issues. In recent years, home-based cardiac rehabilitation, delivered by telerehabilitation, has been suggested as an alternative or adjunct to centre-based cardiac rehabilitation to increase access, adherence, and participation rates. Multiple trials have demonstrated the effectiveness and cost-effectiveness of cardiac telerehabilitation. Recently, the European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC) has defined the presence of a cardiac telerehabilitation programme as one of the quality indicators for centres requesting accreditation. This document aims to provide a clear description of cardiac telerehabilitation and to provide minimal standards and core components to ensure the high quality of cardiac telerehabilitation in Europe.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"1 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144747640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Epicardial adipose tissue and new-onset atrial fibrillation in a Danish cohort. 丹麦队列中的心外膜脂肪组织和新发心房颤动。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-31 DOI: 10.1093/eurheartj/ehaf515

Jonas Jalili Pedersen,Jørgen Tobias Kühl,Marie Bayer Elming,Michael Huy Cuong Pham,Per Ejlstrup Sigvardsen,Børge Grønne Nordestgaard,Andreas Fuchs,Lars Køber,Klaus Fuglsang Kofoed

引用次数: 0

Correction to: Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics. 更正：Scpep1抑制通过改善线粒体生物能量学减轻心肌梗死引起的功能障碍。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-31 DOI: 10.1093/eurheartj/ehaf579

引用次数: 0

Extensive aneurysms resection and left coronary bypass graft in coronary artery-pulmonary artery fistula with grape cluster aneurysms: evaluated by computed tomography angiography. 冠状动脉-肺动脉瘘合并葡萄簇动脉瘤的广泛动脉瘤切除术和左冠状动脉旁路移植术：计算机断层血管造影评价。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-31 DOI: 10.1093/eurheartj/ehaf540

Yue Gao,Yuan Li,Zhi-Gang Yang

引用次数: 0

Avoiding immortal time bias for cardiac transthyretin treatment in aortic stenosis. 避免经甲状腺素治疗主动脉瓣狭窄的不朽时间偏差。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-30 DOI: 10.1093/eurheartj/ehaf542

Christian Nitsche,Robin Ristl,Thomas A Treibel

引用次数: 0

Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction 心力衰竭伴射血分数降低患者住院前后肾功能变化轨迹

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-30 DOI: 10.1093/eurheartj/ehaf457

Masatake Kobayashi, Antoni Bayes-Genis, Kevin Duarte, John J V McMurray, João Pedro Ferreira, Stuart J Pocock, Dirk J Van Veldhuisen, Josep Lupón, Bertram Pitt, Faiez Zannad, Nicolas Girerd

{"title":"Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction","authors":"Masatake Kobayashi, Antoni Bayes-Genis, Kevin Duarte, John J V McMurray, João Pedro Ferreira, Stuart J Pocock, Dirk J Van Veldhuisen, Josep Lupón, Bertram Pitt, Faiez Zannad, Nicolas Girerd","doi":"10.1093/eurheartj/ehaf457","DOIUrl":"https://doi.org/10.1093/eurheartj/ehaf457","url":null,"abstract":"Background and Aims Worsening kidney function is a key prognostic factor in heart failure (HF) with reduced ejection fraction (HFrEF). However, associations between kidney function trajectories and HF-related events remain unclear. Methods Longitudinal changes in estimated glomerular filtration rate (eGFR) before and after a HF-related event, defined as HF hospitalization or HF death, were examined using individual patient data from two clinical trials (EPHESUS and EMPHASIS-HF) and a real-world cohort (BARCELONA). Results HF-related events occurred in 14.1% of 8587 patients [EPHESUS/EMPHASIS-HF; median follow-up 17.1 (12.4–22.7) months] and 33.8% of 2048 patients [BARCELONA; median 47.0 (18.8–90.6) months]. In EPHESUS and EMPHASIS-HF, patients who experienced an HF-related event had a steeper decline in eGFR in the year preceding the event (average −4.83 mL/min/1.73 m²/year) compared with those who did not have an HF-related event (−1.18 mL/min/1.73 m²/year). Over the 1 year following an HF-related event, eGFR continued to decline, though at a slower rate (average −3.45 mL/min/1.73 m²/year). Similar kidney function trajectories were observed in BARCELONA (average eGFR decline −1.35 mL/min/1.73 m²/year in patients without HF event vs −5.77 mL/min/1.73 m²/year 1 year before an event and −3.04 mL/min/1.73 m²/year over the year after an event). Worsening New York Heart Association class paralleled steeper eGFR decline prior to HF events. Conclusions In HFrEF, kidney function decline may precede a HF hospitalization or death by up to 1 year, linking to symptomatic congestion. Monitoring eGFR slopes rather than relying solely on specific cut-off values may allow early detection of at-risk patients.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"149 1","pages":""},"PeriodicalIF":39.3,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144747087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Balloon pericardiotomy for malignant pericardial effusion: the PMAP trial. 球囊心包切开术治疗恶性心包积液：PMAP试验。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-30 DOI: 10.1093/eurheartj/ehaf516

Bryan Ping-Ying Yan,Kevin Ka-Ho Kam,Angel Lai,Canice Lok-Hang Ng,Ngai-Yin Chan,Lap-Shing Chan,Chi-Wing Wong,Ping-Wa Yam,Wai-Kin Chi,Stephen Lam Chan,Randolph Hung Leung Wong,Eugene Brian Wu,Joseph Yat-Sun Chan,Alex Pui-Wai Lee,Guang-Ming Tan

引用次数: 0

Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis. 积极治疗伴有主动脉瓣狭窄的心脏转甲状腺蛋白淀粉样变性的不朽时间偏差。

IF 39.3 1区医学

European Heart Journal Pub Date : 2025-07-30 DOI: 10.1093/eurheartj/ehaf539

Atsuyuki Watanabe,Yuriko Hiruma,Tadashi Asanuma

引用次数: 0